Prosight Management LP Boosts Stock Position in ADC Therapeutics SA (NYSE:ADCT)
Prosight Management LP lifted its holdings in ADC Therapeutics SA (NYSE:ADCT – Free Report) by 603.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,257,360 shares of the company’s stock after purchasing an additional 2,794,050 shares during the quarter. ADC Therapeutics accounts for […]